NCT04829084

Augmenting Referral Pathway to Improve Uptake of Retinal Services by Diabetic Patients

Completed NA Last updated 10 March 2022

What this trial tests

NA trial testing Pre-post educational intervention in Diabetic Retinopathy in 19 participants. Completed in 30 December 2021.

Timeline

26 February 2021

Primary endpoint
30 September 2021

30 December 2021

Quick facts

Lead sponsor	Seva Foundation
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	19
Start date	26 February 2021
Primary completion	30 September 2021
Estimated completion	30 December 2021
Sites	1 location across Nepal

Drugs / interventions tested

• Pre-post educational intervention

Conditions studied

• Diabetic Retinopathy — all drugs for Diabetic Retinopathy →

Sponsor

Seva Foundation

Who can join

20 and older, any sex, with Diabetic Retinopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Reiyukai Eiko Masunaga Eye Hospital (REMEH) is a non-profitable organization. Retina services were resumed from October 2019. Until this retinal service started, it has been mostly cataract-focused. People are unaware of this new retinal service in the hospital. The investigators would like to fill this gap and our objective is to increase the attendance of patients with Diabetes Mellitus, for retinal screening at REMEH by providing health education intervention to selected physicians and establish a referral pathway.

Study Design: pre- post-intervention Methods: The investigators are going to conduct intervention by providing health education on diabetes Retinopathy to the health personnel of Scheer Memorial Hospital. It has been referring eye patients to REMEH as there is no eye department there.

Data Management: The demographic information of health personnel of Sheer memorial and demographic information and other variables of the patient who are referred from Scheer Hospital will be collected and entered in an excel sheet.

The study period of approximately 16 months (March 2020 to Sep 2021): Initial 10 months for proposal writing, preparation, and getting ethical approval. Feb2021 - April 2021 three months for pretest intervention May- July further data collection and last two months Aug- Sep Analysis and writing result.

Results: The proposed outcome is to increase the proportional change in the number of patients availing retinal services and to find out a proportional increase in the number of diabetes screenings from the baseline. Also, a positive outcome is a clear indication for health education, and setting communication between general physicians and specialties will set the path for improvement in a timely health care delivery system.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. "Augmenting the referral pathway for retinal services among diabetic patients at Reiyukai Eiko Masunaga Eye Hospital, Nepal: a non-randomized, pre-post intervention study".
   Shrestha R, Singh P, Dhakwa P, Tetali S, et al · · 2023 · cited 5× · PMID 36750897 · DOI 10.1186/s12913-023-09105-3
2. Augmenting the Referral Pathway for Retinal Services Among Patients With Diabetes Mellitus at Reiyukai Eiko Masunaga Eye Hospital, Nepal: Protocol for a Nonrandomized, Pre-Post Intervention Study.
   Shrestha R, Singh P, Dhakhwa P, Tetali S, et al · · 2021 · cited 2× · PMID 34927596 · DOI 10.2196/33116